Syncom Formulations (India) FCF/Debt

What does Syncom Formulations (India) do? Syncom Formulations (India) Ltd generates revenue through the manufacturing and marketing of pharmaceutical formulations across various dosage forms including tablets, capsules, injections, and topical preparations. The company's domestic division focuses on branded product lines such as Cratus Life Care, Cratus Evolve, and Cratus Right Nutrition, which include specific products like Ciprofloxacin Tablets USP 250 mg, Cefazolin For Injection USP 1 gm, and Ceftriaxone for Injection USP 500 mg. These products are sold to healthcare providers and pharmacies within India's domestic market. The firm also engages in commodity trading and property rental activities to diversify its income streams. The company's primary revenue drivers are its pharmaceutical product categories, which target healthcare professionals and retail pharmacies for distribution. Cratus Life Care, Cratus Evolve, and Cratus Right Nutrition represent distinct brand segments within the domestic division, each catering to specific therapeutic needs. The product portfolio includes both generic and branded formulations, with a focus on antibiotics and injectable solutions for acute medical conditions. Syncom Formulations' business model integrates manufacturing, marketing, and distribution of healthcare products under its branded lines. The domestic division's product categories serve as the core revenue source, while commodity trading and property rental provide supplementary income. The company's product range spans from oral medications to specialized injectables, targeting both hospital and retail pharmacy channels for sales. Syncom Formulations (India) is one of the most popular companies on Eulerpool.